Ketamine is a potent dissociative anesthetic used for pain management in various settings. It blocks the N-methyl-D-aspartate (NMDA) receptor, reduces pain perception, and provides analgesia. Ketamine has been used to manage acute and chronic pain, including neuropathic pain, cancer pain, and postoperative pain. However, its use in pain management is still under investigation, and there is a need for further research to determine its efficacy, Safety, and optimal dosing in various populations.

Let’s delve deeper into ketamine therapy for pain management, including the current research supporting its use and the potential risks that should be considered.

What is Ketamine?

Ketamine was first approved by the FDA in 1970 as an anesthetic and sedative medication. Since then, it has been approved for various uses, including as a veterinary anesthetic and treatment for treatment-resistant depression.

In 2019, the FDA approved ketamine nasal spray formulation of ketamine for use in treating depression in adults who have not responded to other treatments. The brand name for this medication is Spravato.

Ketamine is also commonly used off-label for managing chronic pain, including neuropathic pain, cancer pain, and postoperative pain. However, its use for these purposes is not FDA-approved, and there is ongoing research to determine its efficacy and Safety in these contexts.

Other brand names for ketamine include Ketalar and Ketaset, used primarily as an anesthetic and sedative in medical procedures.

How Does Ketamine Work?

Ketamine blocks the N-methyl-D-aspartate (NMDA) receptor, which transmits brain and spinal cord pain signals. By blocking this receptor, ketamine reduces pain perception and provides analgesia.

In addition to its effects on pain perception, ketamine has various other effects on the brain and body. It has been shown to increase the release of certain neurotransmitters, such as glutamate and dopamine, which are involved in mood regulation and motivation.

Ketamine also has dissociative and hallucinogenic effects, which are thought to be related to its impact on the brain’s glutamate system. Specifically, ketamine has been shown to increase the activity of a different type of glutamate receptor, called the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor. This increased activity may contribute to the hallucinogenic and dissociative effects of ketamine.

Overall, the mechanisms of action of ketamine are complex and not fully understood. However, its effects on the NMDA and AMPA receptors are thought to be the primary mechanisms by which it produces its analgesic and mood-altering effects.

Ketamine Helps Pain: How Effectively?

Ketamine therapy has shown promise in treating various types of chronic pain, particularly neuropathic pain, and pain resistant to other treatments. Ketamine blocks the N-methyl-D-aspartate (NMDA) receptor, which transmits brain and spinal cord pain signals. By blocking this receptor, ketamine can reduce pain perception and provide analgesia.

Ketamine therapy typically involves low-dose infusions of ketamine over several hours, either in a hospital or outpatient setting. The goal of ketamine therapy for pain is to provide relief from pain and improve overall function and quality of life.

Research on the effectiveness of ketamine for pain has yielded mixed results. While some studies have shown significant pain reduction and improved function following ketamine therapy, others have found little benefit. Additionally, there is limited data on the long-term effects of ketamine therapy for pain, particularly regarding the risk of addiction or other adverse effects.

Despite these limitations, ketamine therapy remains an option for individuals with chronic pain who have not responded to other treatments. It is essential to work closely with a healthcare professional to determine whether ketamine therapy is appropriate for your specific needs and to monitor for potential side effects and complications.

What Is The Purpose Of Ketamine Therapy?

Ketamine therapy involves low-dose infusions of ketamine over several hours to relieve chronic pain. The process includes medical evaluation, preparation, information, recovery, and follow-up appointments. Multiple inputs may be needed depending on the individual’s response to treatment. It is essential to work with a healthcare provider to determine if ketamine therapy is appropriate and to monitor for potential side effects and complications.

Ketamine for acute postoperative pain

Ketamine is effective in treating acute postoperative pain, with multiple studies demonstrating its efficacy in reducing pain scores and decreasing opioid consumption. However, ketamine can also have adverse effects, including hallucinations, confusion, and cardiovascular and respiratory depression.

When considering ketamine for acute postoperative pain, weigh the potential benefits and risks carefully. Ketamine should be used cautiously in individuals with a history of substance abuse, psychiatric disorders, or cardiovascular or respiratory disease. Close monitoring of vital signs and mental status is recommended during ketamine administration.

Overall, ketamine may be a valuable option for managing acute postoperative pain, but it should be used judiciously and with appropriate monitoring to ensure safety and efficacy.

Ketamine for opioid-resistant pain in palliative care

Ketamine has shown promise as a treatment option for opioid-resistant pain in palliative care patients. Evidence suggests that ketamine can provide significant pain relief, particularly for neuropathic pain, and may have a lower risk of respiratory depression than opioids. However, there are potential adverse effects associated with ketamine, including dissociative symptoms and cardiovascular effects, which must be carefully monitored.

Clinicians should carefully consider the patient’s medical history and current medications when deciding whether ketamine therapy is appropriate. Additionally, ketamine therapy should be administered under close supervision in a hospital or outpatient setting, with proper monitoring and support for potential adverse effects.

Overall, while ketamine may be a valuable treatment option for opioid-resistant pain in palliative care, it is essential to weigh the potential benefits and risks and to monitor patients for adverse effects carefully. Close collaboration between healthcare providers and patients can help ensure the safe and effective use of ketamine therapy in this population.

Ketamine for chronic noncancer pain

Ketamine has been used to treat chronic noncancer pain, but the evidence for its efficacy is mixed. Some studies have shown significant pain reduction and improved function, while others have found little benefit. Adverse effects can include nausea, vomiting, dizziness, and dissociative effects. Clinical considerations include patient selection, dosing, monitoring for adverse effects, and evaluating the risk of addiction or other long-term consequences. Ketamine therapy for chronic pain should be approached with caution and under the guidance of a healthcare professional.

Ketamine Side Effects

Ketamine is a potent medication with many common and severe side effects. Common side effects of ketamine may include:

  • Nausea and vomiting
  • Dizziness or lightheadedness
  • Vision changes, such as hazy or double-vision
  • Confusion or disorientation
  • Feeling detached from one’s body or surroundings
  • Euphoria or a sense of dissociation
  • Increased heart rate or blood pressure

These common side effects are generally mild and short-lived and often resolve independently without intervention.

However, ketamine can also cause more severe side effects, mainly when used in higher doses or for more extended periods. These severe side effects may include:

  • Respiratory depression or respiratory arrest
  • Cardiovascular depression, including low blood pressure or irregular heartbeat
  • Seizures or convulsions
  • Delirium or psychosis
  • Hallucinations or other perceptual disturbances
  • Increased risk of injury or accidents

In rare cases, ketamine use can also lead to persistent or long-term side effects, such as cognitive impairment, memory problems, or changes in mood or behavior.

It is important to note that ketamine has a high potential for abuse and dependence, mainly when used recreationally or outside medical supervision. Long-term or high-dose ketamine use can lead to addiction, tolerance, and withdrawal symptoms, which can be severe and complex to manage.

If you experience any of these adverse effects or have any concerns about using ketamine, you should consult with a medical practitioner as soon as possible. They can assist you in weighing the risks and advantages of ketamine and determining the best course of treatment for your unique requirements.

Final Words From AzDrug

Ketamine is a drug that can help with pain management, but the way it’s used can vary, and there are concerns about side effects. High doses should be avoided, and oral or spinal administration can cause problems. Ketamine can reduce pain and the need for opioids after surgery. It may help with palliative care, but more research is needed. There is limited evidence for using ketamine for chronic noncancer pain, and intermittent infusions are not recommended.

Also read:

Disclaimer: Please see your healthcare practitioner for any medical queries or concerns. Peer-reviewed research and information from medical societies and government agencies are used to support the articles in Health Guide. They are not, however, a replacement for expert medical advice, diagnosis, or treatment.

  • Bell, Rae Frances, and Eija Anneli Kalso. “Ketamine for Pain Management.” PAIN Reports, vol. 3, no. 5, 2018, p. e674, https://doi.org/10.1097/pr9.0000000000000674. Accessed 30 Apr. 2023.
  • Brown, Kyle, and Calvin Tucker. “Ketamine for Acute Pain Management and Sedation.” Critical Care Nurse, vol. 40, no. 5, Oct. 2020, pp. e26–32, https://doi.org/10.4037/ccn2020419. Accessed 1 May 2023.
  • Cohen, Steven P., et al. “Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.” Regional Anesthesia and Pain Medicine, vol. 43, no. 5, June 2018, p. 1, https://doi.org/10.1097/aap.0000000000000808. Accessed 1 May 2023.
  • Corriger, Alexandrine, et al. “Ketamine for Refractory Chronic Pain.” Pain, vol. Publish Ahead of Print, July 2021, https://doi.org/10.1097/j.pain.0000000000002403. Accessed 1 May 2023.
  • Culp, Clayton, et al. “Ketamine Use for Cancer and Chronic Pain Management.” Frontiers in Pharmacology, vol. 11, Feb. 2021, https://doi.org/10.3389/fphar.2020.599721. Accessed 1 May 2023.
  • Niesters, Marieke, et al. “Ketamine for Chronic Pain: Risks and Benefits.” British Journal of Clinical Pharmacology, vol. 77, no. 2, Jan. 2014, pp. 357–67, https://doi.org/10.1111/bcp.12094. Accessed 30 Apr. 2023.
  • Orhurhu, Vwaire, et al. “Ketamine Infusions for Chronic Pain.” Anesthesia & Analgesia, vol. 129, no. 1, July 2019, pp. 241–54, https://doi.org/10.1213/ane.0000000000004185. Accessed 1 May 2023.

Share Post On:

Recent Blogs